Cue Biopharma Inc. (CUE)
undefined
undefined%
At close: undefined
0.97
3.18%
After-hours Dec 13, 2024, 07:39 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -50.73M -53.01M -44.16M -44.78M -36.70M -38.98M -23.23M -7.66M -1.93M
Depreciation & Amortization 3.44M 1.81M -1.78M 1.06M 5.17M 760.01K 419.57K 202.09K 44.81K
Stock-Based Compensation 8.18M 9.50M 11.52M 10.48M 6.52M 7.17M 2.78M 889.56K -
Other Working Capital -63.00K -2.81M -7.97M -3.70M 928.59K 3.83M 2.35M 532.32K -31.01K
Other Non-Cash Items 90.00K -453.78K -26.13K -563.23K -4.28M 345.10K 4.93M 65.91K 79.55K
Deferred Income Tax - - - 83.69K -18.19K 79.86K 10.68K - -
Change in Working Capital -934.00K 356.27K -4.39M 1.23M -1.49M 4.21M 2.91M 532.32K 146.80K
Operating Cash Flow -39.96M -41.81M -38.84M -32.49M -30.80M -26.41M -12.19M -5.97M -1.66M
Capital Expenditures - -170.75K -913.04K -595.26K -46.35K -1.85M -1.20M -515.98K -754.29K
Acquisitions - 6.21K 4.58K 83.69K 127.50K - - - -
Purchase of Investments - -29.45M -4.58K -9.95M -15.13M -39.50M - - -
Sales Maturities Of Investments 25.00M 5.00M 10.00M 15.00M 18.50M 21.00M - - -
Other Investing Acitivies 2.00K -24.44M 21.55K -83.69K 3.49M -18.50M -35 -33 -50.00K
Investing Cash Flow 25.00M -24.61M 9.11M 4.46M 3.45M -20.35M -1.20M -516.01K -804.29K
Debt Repayment -2.00M 10.00M - - - - - - -
Common Stock Repurchased - - - -271.05K -91.03K - -4.16M -1.41M -1.14M
Dividend Paid - - - - - - - - -
Other Financial Acitivies 473.00K 4.36M 1.85M 1.93M 1.79M 12.50K 9.01K - 1K
Financial Cash Flow 11.86M 53.66M 19.23M 58.61M 50.79M 4.18M 62.00M 15.01M 8.87M
Net Cash Flow -3.10M -12.76M -10.50M 30.58M 23.44M -42.58M 48.61M 8.52M 6.41M
Free Cash Flow -39.96M -41.98M -39.75M -33.09M -30.84M -28.27M -13.40M -6.48M -2.41M